Fig. 4From: Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugsDrug screening of 786–0 WT cells. A) Diagram showing the drug screening. B) Viability of 786–0 WT and 786–0 WT cells transfected with siCON or siHIF2α and treated with 2.5 μM statins or 50 μM terbinafine +/− 10 μM PT2385 (PT) during 5 days relative to cells treated with DMSO. n = 3. * p < 0.05, ** p < 0.01, *** p < 0.001. Errors bars depict standard error of the meanBack to article page